266 billion won of business losses on Bio test scandals.

Published: 2006-10-23 06:59:00

Updated: 2006-10-23 06:59:00

The KPMA reported that the government administrative measures against 287 drugs in charge of the bio equivalency test frauds resulted in about 266 billion won of economic losses a year, which excepted other losses accrued from a defamed industrial prestige and a loss of generic drug credibility. ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK